284 related articles for article (PubMed ID: 9027347)
41. A receptor binding site identified in the region 81-95 of the beta-subunit of human luteinizing hormone (LH) and chorionic gonadotropin (hCG).
Morbeck DE; Roche PC; Keutmann HT; McCormick DJ
Mol Cell Endocrinol; 1993 Nov; 97(1-2):173-81. PubMed ID: 8143901
[TBL] [Abstract][Full Text] [Related]
42. Structural features of mammalian gonadotropins.
Bousfield GR; Butnev VY; Gotschall RR; Baker VL; Moore WT
Mol Cell Endocrinol; 1996 Dec; 125(1-2):3-19. PubMed ID: 9027339
[TBL] [Abstract][Full Text] [Related]
43. Co-evolution of ligand-receptor pairs.
Moyle WR; Campbell RK; Myers RV; Bernard MP; Han Y; Wang X
Nature; 1994 Mar; 368(6468):251-5. PubMed ID: 8145825
[TBL] [Abstract][Full Text] [Related]
44. Probing the receptor-interaction of glycoprotein hormones with monoclonal antibodies.
Schwarz S; Berger P; Nelboeck E; Khashabi D; Panmoung W; Klieber R; Wick G
J Recept Res; 1988; 8(1-4):437-53. PubMed ID: 2455048
[TBL] [Abstract][Full Text] [Related]
45. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
Alvarez CA; Narayan P; Huang J; Puett D
Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
[TBL] [Abstract][Full Text] [Related]
46. Deglycosylated human chorionic gonadotropin (hCG) antagonizes hCG stimulation of 3',5'-cyclic adenosine monophosphate accumulation through a noncompetitive interaction with recombinant human luteinizing hormone receptors.
Dunkel L; Jia XC; Nishimori K; Boime I; Hsueh AJ
Endocrinology; 1993 Feb; 132(2):763-9. PubMed ID: 8381073
[TBL] [Abstract][Full Text] [Related]
47. Expression of human luteinizing hormone (LH) receptor: interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species.
Jia XC; Oikawa M; Bo M; Tanaka T; Ny T; Boime I; Hsueh AJ
Mol Endocrinol; 1991 Jun; 5(6):759-68. PubMed ID: 1922095
[TBL] [Abstract][Full Text] [Related]
48. Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.
Nagayama Y; Wadsworth HL; Chazenbalk GD; Russo D; Seto P; Rapoport B
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):902-5. PubMed ID: 1992482
[TBL] [Abstract][Full Text] [Related]
49. Mapping the receptor binding regions of human chorionic gonadotropin (hCG) using disulfide peptides of its beta-subunit: possible involvement of the disulfide bonds Cys(9)-Cys(57) and Cys(23)-Cys(72) in receptor binding of the hormone.
Mishra AK; Mahale SD; Iyer KS
J Pept Res; 2001 Jul; 58(1):17-26. PubMed ID: 11454166
[TBL] [Abstract][Full Text] [Related]
50. Highly-Sensitive In Vitro Bioassays for FSH, TSH, PTH, Kp, and OT in Addition to LH in Mouse Leydig Tumor Cell.
Klett D; Pellissier L; Lomet D; Derouin-Tochon F; Robert V; Nguyen TMD; Duittoz A; Reiter E; Locatelli Y; Dupont J; Dardente H; Jean-Alphonse F; Combarnous Y
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569429
[TBL] [Abstract][Full Text] [Related]
51. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor.
Rozzell TG; Wang H; Liu X; Segaloff DL
Mol Endocrinol; 1995 Dec; 9(12):1727-36. PubMed ID: 8614409
[TBL] [Abstract][Full Text] [Related]
52. Modulation of high affinity hormone binding. Human choriogonadotropin binding to the exodomain of the receptor is influenced by exoloop 2 of the receptor.
Ryu K; Lee H; Kim S; Beauchamp J; Tung CS; Isaacs NW; Ji I; Ji TH
J Biol Chem; 1998 Mar; 273(11):6285-91. PubMed ID: 9497355
[TBL] [Abstract][Full Text] [Related]
53. A subunit interaction site in human luteinizing hormone: identification by photoaffinity cross-linking.
Keutmann HT; Rubin DA
Endocrinology; 1993 Mar; 132(3):1305-12. PubMed ID: 7679977
[TBL] [Abstract][Full Text] [Related]
54. Human chorionic gonadotropin (CG)- and phorbol ester-stimulated phosphorylation of the luteinizing hormone/CG receptor maps to serines 635, 639, 649, and 652 in the C-terminal cytoplasmic tail.
Hipkin RW; Wang Z; Ascoli M
Mol Endocrinol; 1995 Feb; 9(2):151-8. PubMed ID: 7776965
[TBL] [Abstract][Full Text] [Related]
55. Changes in ovarian luteinizing hormone and follicle-stimulating hormone receptor content and in gonadotropin-induced ornithine decarboxylase activity during prepubertal and pubertal development of the female rat.
White SS; Ojeda SR
Endocrinology; 1981 Jul; 109(1):152-61. PubMed ID: 6263582
[TBL] [Abstract][Full Text] [Related]
56. Identification of Key Receptor Residues Discriminating Human Chorionic Gonadotropin (hCG)- and Luteinizing Hormone (LH)-Specific Signaling.
Lazzaretti C; Secco V; Paradiso E; Sperduti S; Rutz C; Kreuchwig A; Krause G; Simoni M; Casarini L
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375708
[TBL] [Abstract][Full Text] [Related]
57. Conversion of human choriogonadotropin into a follitropin by protein engineering.
Campbell RK; Dean-Emig DM; Moyle WR
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):760-4. PubMed ID: 1899483
[TBL] [Abstract][Full Text] [Related]
58. A synthetic peptide corresponding to amino acids 9-30 of the extracellular domain of the follitropin (FSH) receptor specifically binds FSH.
Dattatreyamurty B; Reichert LE
Mol Cell Endocrinol; 1992 Sep; 87(1-3):9-17. PubMed ID: 1446790
[TBL] [Abstract][Full Text] [Related]
59. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors.
Quintana J; Wang H; Ascoli M
Mol Endocrinol; 1993 Jun; 7(6):767-75. PubMed ID: 8395653
[TBL] [Abstract][Full Text] [Related]
60. Unmasking of an immunoreactive site on the alpha subunit of human choriogonadotropin bound to the extracellular domain of its receptor.
Pantel J; Remy JJ; Salesse R; Jolivet A; Bidart JM
Biochem Biophys Res Commun; 1993 Sep; 195(2):588-93. PubMed ID: 7690556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
